We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Yvette
Wagner
yvette.wagner@sussexpartnership.nhs.uk
Ilona
Bowyer
i.bowyer@sussex.ac.uk
Miriam
Hiersch
mkh29@sussex.ac.uk
Siva
Sangaralingham
siva.sangaralingham@nihr.ac.uk
Miriam
Hiersch
mkh29@sussex.ac.uk
Mr
Matthew
Smith
spft.researchgovernance@nhs.net
Miriam
Hiersch
mkh29@sussex.ac.uk
Schizophrenia, schizotypal and delusional disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Therapist qualities (e.g. empathy) can affect the therapeutic relationship and treatment outcomes and are more important for people with severe mental illnesses (e.g. psychosis). A developing area within psychosis care is the utilisation of briefly trained psychological practitioners (e.g. assistant psychologists) who deliver short interventions. This reduces the resources needed and might make treatments more accessible. Feedback from studies testing this approach has suggested that the personal qualities of these psychological practitioners might be particularly important. Measuring these qualities might ensure that referring clinicians trust practitioners, are willing to refer patients to them and that patients trust the practitioners, too.
Therefore, this study aims to develop and test a screening tool to measure psychological practitioners' personal qualities. The second part of the study will then test whether the scores on the screening tool predict trust ratings given by clinicians towards the therapist.
First, we will develop three roleplay scenarios of three common psychosis patient presentations along with a screening tool questionnaire measuring therapist qualities. Then, we will invite 60 participants with differing therapy experience levels to participate in these roleplays. Their performance will be video-recorded. A group of 10 expert clinicians will then watch some example videos and provide feedback on the screening tool measure. The screening tool will be adjusted according to these suggestions.
The study's second phase will involve an online questionnaire with 180 clinicians. They will watch one randomly selected video and respond to the screening tool, as well as a trust questionnaire along with existing questionnaires on therapist empathy and related qualities.
The data analysis will then assess whether the screening tool is valid and reliable and whether screening tool scores predict trust ratings. This analysis will also show whether screening tool scores differ depending on patient presentation or practitioner training level.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Validation of outcome measures;
You can take part if:
You may not be able to take part if:
Exclusion criteria for performance task (phase 1): (1) Below 18 years of age (2) Participants with current self-reported mental health issues that might cause distress while taking part in the roleplay scenarios. (3) Lack of capacity to provide informed consent (4) Insufficient grasp of the English language to enable roleplay participation Exclusion criteria for phase 2: (1) Staff members with no experience of psychosis patients (2) Aged below 18 years (3) Lack of capacity to provide informed consent (4) Insufficient grasp of the English language to enable questionnaire completion (5) Participants with current mental health issues that might cause distress while watching the roleplay scenarios.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Miriam
Hiersch
mkh29@sussex.ac.uk
Miriam
Hiersch
mkh29@sussex.ac.uk
Mr
Matthew
Smith
spft.researchgovernance@nhs.net
Siva
Sangaralingham
siva.sangaralingham@nihr.ac.uk
Yvette
Wagner
yvette.wagner@sussexpartnership.nhs.uk
Ilona
Bowyer
i.bowyer@sussex.ac.uk
Miriam
Hiersch
mkh29@sussex.ac.uk
The study is sponsored by University of Sussex and funded by Economic and Social Research Council (ESRC) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 62713
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
